Covered recipient · General Payments record
ROLONDO BROWN
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2021–2024
$397.43
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $204.52 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $50.38 | 2 |
| PFIZER INC. | $48.12 | 2 |
| Amgen Inc. | $25.84 | 1 |
| Melinta Therapeutics, Inc. | $25.84 | 1 |
| Solventum Corporation | $20.65 | 1 |
| Gilead Sciences, Inc. | $20.52 | 1 |
| Acerta Pharma LLC | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $23.87 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093934696 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094048276 | CMS |
| Amgen Inc. | $25.84 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115465537 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.17 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104419263 | CMS |
| Gilead Sciences, Inc. | $20.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838834 | CMS |
| Melinta Therapeutics, LLC | $25.84 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140485219 | CMS |
| PFIZER INC. | $25.38 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576765 | CMS |
| PFIZER INC. | $22.74 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132083538 | CMS |
| Solventum Corporation | $20.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144079510 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.